𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mesenchymal stem cell modification of endothelial matrix regulates their vascular differentiation

✍ Scribed by Thomas P. Lozito; Juan M. Taboas; Catherine K. Kuo; Rocky S. Tuan


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
314 KB
Volume
107
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Mesenchymal stem cells (MSCs) respond to a variety of differentiation signal provided by their local environments. A large portion of these signals originate from the extracellular matrix (ECM). At the same time, MSCs secrete various matrix‐altering agents, including proteases, that alter ECM‐encoded differentiation signals. Here we investigated the interactions between MSC and ECM produced by endothelial cells (EC‐matrix), focusing not only on the differentiation signals provided by EC‐matrix, but also on MSC‐alteration of these signals and the resultant affects on MSC differentiation. MSCs were cultured on EC‐matrix modified in one of three distinct ways. First, MSCs cultured on native EC‐matrix underwent endothelial cell (EC) differentiation early during the culture period and smooth muscle cell (SMC) differentiation at later time points. Second, MSCs cultured on crosslinked EC‐matrix, which is resistant to MSC modification, differentiated towards an EC lineage only. Third, MSCs cultured on EC‐matrix pre‐modified by MSCs underwent SMC‐differentiation only. These MSC‐induced matrix alterations were found to deplete the factors responsible for EC‐differentiation, yet activate the SMC‐differentiation factors. In conclusion, our results demonstrate that the EC‐matrix contains factors that support MSC differentiation into both ECs and SMCs, and that these factors are modified by MSC‐secreted agents. By analyzing the framework by which EC‐matrix regulates differentiation in MSCs, we have uncovered evidence of a feedback system in which MSCs are able to alter the very matrix signals acting upon them. J. Cell. Biochem. 107: 706–713, 2009. Published 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Human mesenchymal stem cells express vas
✍ Thomas P. Lozito; Catherine K. Kuo; Juan M. Taboas; Rocky S. Tuan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

## Abstract Mesenchymal stem cells (MSCs) are thought to occupy a perivascular niche where they are exposed to signals originating from vascular cells. This study focused on the effects of endothelial cell (EC)‐derived signals on MSC differentiation toward vascular cell lineages. Upon co‐culture wi

Adenoviral expression of vascular endoth
✍ Huey Lin; Arsalan Shabbir; Merced Molnar; Jingwei Yang; Susan Marion; John M. Ca 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB

## Abstract Bone marrow‐derived mesenchymal stem cells (MSCs) are being explored for clinical applications, and genetic engineering represents a useful strategy for boosting the therapeutic potency of MSCs. Vascular endothelial growth factor (VEGF)‐based gene therapy protocols have been used to tre

Vascular endothelial growth factor (VEGF
✍ Hubert Mayer; Helge Bertram; Werner Lindenmaier; Thomas Korff; Holger Weber; Her 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

## Abstract Angiogenesis is essential in bone fracture healing for restoring blood flow to the fracture site. Vascular endothelial growth factor (VEGF) and its receptor have been implicated in this process. Despite the importance of angiogenesis for the healing processes of damaged bones, the role

Osteogenic differentiation of human mese
✍ Michael S. Friedman; Michael W. Long; Kurt D. Hankenson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 452 KB 👁 1 views

## Abstract Bone marrow‐derived mesenchymal stem cells (MSC) are multipotent, self‐renewing, mesodermal‐origin stem cells that are sequestered in the endosteal compartment. MSC are maintained in a relative state of quiescence in vivo but in response to a variety of physiological and pathological st

Sortilin is upregulated during osteoblas
✍ Shingo Maeda; Takahiro Nobukuni; Kazuki Shimo-Onoda; Kyoji Hayashi; Kazunori Yon 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

Osteoblasts and adipocytes are derived from a common precursor in bone marrow, the mesenchymal stem cell (MSC). Factors driving human MSCs (hMSCs) to differentiate down the two lineages play important roles in determining bone density because it has been shown that bone volume loss associated with o